Literature DB >> 15558317

A family with pyruvate dehydrogenase complex deficiency due to a novel C>T substitution at nucleotide position 407 in exon 4 of the X-linked Epsilon1alpha gene.

Már Tulinius1, Niklas Darin, Lars-Martin Wiklund, Eva Holmberg, Jan Erik Eriksson, Willy Lissens, Linda De Meirleir, Elisabeth Holme.   

Abstract

UNLABELLED: The pyruvate dehydrogenase complex (PDHc; McKusick 312170), localised in the mitochondrial matrix, is a multienzyme complex which converts pyruvate to acetyl-CoA. A deficiency of PDHc leads to inadequate removal of pyruvate and lactate resulting in lactic acidaemia and insufficient energy production. The major cause of PDHc deficiency is a defect in the E1alpha component. The gene of this component is localised to Xp22.1. We describe two brothers with a relatively mild clinical phenotype of PDHc deficiency. Onset of disease was associated with muscle weakness and swallowing difficulties in both. At follow-up, the older brother developed encephalopathic features consistent with Leigh syndrome. Lactate to pyruvate ratios were low, consistent with a PDHc deficiency which was confirmed by measurements of PDHc activity in thrombocytes. A 407C>T change in exon 4 of the E1alpha gene was found in both brothers and their mother. This substitution predicts a replacement of a conserved alanine at position 136 by valine.
CONCLUSION: Due to the X-linked inheritance pattern combined with the overall results of clinical investigations, molecular genetic findings and a corresponding functional deficiency of the gene product we believe that this substitution in the pyruvate dehydrogenase E1alpha gene is a mutation leading to pyruvate dehydrogenase complex deficiency in this family.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15558317     DOI: 10.1007/s00431-004-1570-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  Thiamine-responsive pyruvate dehydrogenase deficiency in two patients caused by a point mutation (F205L and L216F) within the thiamine pyrophosphate binding region.

Authors:  Etsuo Naito; Michinori Ito; Ichiro Yokota; Takahiko Saijo; Junko Matsuda; Yukiko Ogawa; Seiko Kitamura; Eiko Takada; Yoshihiro Horii; Yasuhiro Kuroda
Journal:  Biochim Biophys Acta       Date:  2002-10-09

Review 2.  Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency.

Authors:  W Lissens; L De Meirleir; S Seneca; I Liebaers; G K Brown; R M Brown; M Ito; E Naito; Y Kuroda; D S Kerr; I D Wexler; M S Patel; B H Robinson; A Seyda
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

3.  Cerebral palsy and pyruvate dehydrogenase deficiency: identification of two new mutations in the E1alpha gene.

Authors:  W Lissens; P Vreken; P G Barth; F A Wijburg; W Ruitenbeek; R J Wanders; S Seneca; I Liebaers; L De Meirleir
Journal:  Eur J Pediatr       Date:  1999-10       Impact factor: 3.183

4.  Rapid diagnosis of pyruvate and ketoglutarate dehydrogenase deficiencies in platelet-enriched preparations from blood.

Authors:  J P Blass; S D Cederbaum; R A Kark
Journal:  Clin Chim Acta       Date:  1977-02-15       Impact factor: 3.786

5.  Introduction of a ketogenic diet in young infants.

Authors:  J Klepper; B Leiendecker; R Bredahl; S Athanassopoulos; F Heinen; E Gertsen; A Flörcken; A Metz; T Voit
Journal:  J Inherit Metab Dis       Date:  2002-10       Impact factor: 4.982

6.  Mitochondrial encephalomyopathies in childhood. I. Biochemical and morphologic investigations.

Authors:  M H Tulinius; E Holme; B Kristiansson; N G Larsson; A Oldfors
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

7.  The effect of Mycoplasma contamination on the in vitro assay of pyruvate dehydrogenase activity in cultured fibroblasts.

Authors:  A F Clark; D F Farrell; W Burke; C R Scott
Journal:  Clin Chim Acta       Date:  1978-01-02       Impact factor: 3.786

  7 in total
  6 in total

Review 1.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

2.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2012-07       Impact factor: 4.797

3.  MRI features of 4 female patients with pyruvate dehydrogenase E1 alpha deficiency.

Authors:  Nicholas Ah Mew; Johanna B Loewenstein; Nadja Kadom; Uta Lichter-Konecki; Andrea L Gropman; Jodie M Martin; Adeline Vanderver
Journal:  Pediatr Neurol       Date:  2011-07       Impact factor: 3.372

4.  Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency.

Authors:  Francois-G Debray; Marie Lambert; Michel Vanasse; Jean-Claude Decarie; Jessie Cameron; Valeriy Levandovskiy; Brian H Robinson; Grant A Mitchell
Journal:  Eur J Pediatr       Date:  2006-03-22       Impact factor: 3.183

Review 5.  The in-depth evaluation of suspected mitochondrial disease.

Authors:  Richard H Haas; Sumit Parikh; Marni J Falk; Russell P Saneto; Nicole I Wolf; Niklas Darin; Lee-Jun Wong; Bruce H Cohen; Robert K Naviaux
Journal:  Mol Genet Metab       Date:  2008-02-01       Impact factor: 4.797

6.  Pyruvate dehydrogenase deficiency disease detected by the enzyme activity of peripheral leukocytes.

Authors:  YanYan Ma; YaoGang Zhang; Tao Zhang; Zhu Man; XiaoMing Su; ShuJing Hao; TianZe Wang
Journal:  Mol Genet Genomic Med       Date:  2021-06-22       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.